Abstract
Objectives: This study examined the indications, efficacy and outcomes of implantable cardioverter defibrillator (ICD) use in the pediatric population.
Background: ICDs are first-line therapy for adults resuscitated from sudden cardiac death (SCD) or at high risk for life-threatening ventricular arrhythmias. Use of ICDs in children and young adults is infrequent and there are few data regarding this group.
Methods: We abstracted and analyzed data for all patients in whom ICDs were implanted.
Results: A total of 38 devices were implanted in 27 patients. Age ranged from 6 to 26 years (mean, 14) and weight ranged from 16 to 124 kg (mean, 47). Diagnoses included long QT syndrome (9), hypertrophic cardiomyopathy [6], repaired congenital heart disease [5];, and idiopathic ventricular tachycardia/fibrillation [4]. Indications comprised resuscitated SCD [15], syncope [9], and life-threatening ventricular arrhythmia [3]. Initial device placement was infraclavicular in 13, abdominal in 13 and intrathoracic in 1. Epicardial leads were used with 5 systems. A single coil lead was used in 17. Seven patients, all previously resuscitated from SCD, experienced 88 appropriate successful discharges. There were 6 inappropriate discharges in 3 patients. Mean time to device replacement was 3.1 years (n = 11). Complications included 2 infected systems, 2 lead dislodgments, 2 lead fractures, 1 post-pericardiotomy syndrome, 1 adverse event with defibrillation threshold (DFT); testing, and 1 patient with psychiatric sequelae. No deaths occurred with implanted ICDs.
Conclusions: These data demonstrate that ICDs provide safe and effective therapy in young patients. The indications for ICDs as primary preventive therapy remain uncertain.
Article PDF
Similar content being viewed by others
References
Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322–324.
Moss AJ, Hall WJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933–1940.
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882–1890.
Kral MA, Spotnitz HM, Hordof A, Bigger JT, Steinberg JS, Livelli FD. Automatic implantable cardioverter defibrillator implantation for malignant ventricular arrhythmias associated with congenital heart disease. Am J Cardiol 1989;63:118–119.
Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 1998;97:1325–1335.
Kron J, Oliver RP, Norsted S, Silka MJ. The automatic implantable cardioverter-defibrillator in young patients. J Am Coll Cardiol 1990;16:896–902. 244 Stefanelli et al.
Silka MJ, Kron J, Dunnigan A, Dick M, II. Sudden cardiac death and the use of implantable cardioverer-defibrillators in pediatric patients. Circulation 1993;87:800–807.
Kron J, Silka MJ, Ohm O-J, Bardy G, Benditt D. Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients. PACE 1994;17:26–30.
Silka MJ, Kron J, Halperin BD. Current experience with transvenous implantable cardioverter defibrillators systems in patients younger than 21 years of age. J Am Coll Cardiol 1996;27:397A.
Kaminer SJ, Pickoff AS, Dunnigan A, Sterba R, Wolff GS. Cardiomyopathy and the use of implanted cardio-defibrillators in children. PACE 1990;13:593–597.
Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996;77:524–526.
Wilson WR, Greer GE, Grubb BP. Implantable cardioverter-defibrillators in children: a single institutional experience. Ann Thorac Surg 1998;65:775–778.
Link MS, Hill SL, Cliff DL, et al. Comparison of the frequency of complications of implantable cardioverterdefibrillators in children versus adults. Am J Cardiol 1999;83:263–266.
Fischbach PS, Law IH, Dick M, II, Leroy S, Mosca RS, Serwer GA. Use of a single coil transvenous electrode with an abdominally placed implantable cardioverter defibrillator in children. PACE 2000;23:884–887.
Gradaus R, Hammel D, Kotthoff S, Böcker D. Nonthoracotomy implantable cardioverter defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter de-fibrillators in children. J Cardiovasc Electrophys 2001;12:356–360.
Park JK, Pollock ME. Use of an implantable cardioverter defibrillator in an eight-month-old infant with ventricular fibrillation arising from a myocardial fibroma. PACE 1999;22:138–139.
Dumont C, Dumont L, Mardirosoff C, DeVille A. Placement of an automatic cardioverter-defibrillator in a 6-month-old infant: anesthetic management. J Cardiothorac Vasc Anesth 2000;14:63–65.
Silka MJ. Implantable cardioverter-defibrillators in children: a perspective on current and future uses. Journal Electrocardiol 1996;29:223–225.
Fischbach PS, Stefanelli CB, Bradley DJ, Leroy S, Dick M, II, Serwer GA. Necessity of follow-up defibrillation testing in pediatric patients with ICDs. PACE 2001;24:570A.
Brunn J, Böcker D, Weber M, et al. Is there a need for routine testing of ICD defibrillation capacity? Results for more than 1000 studies. Eur Heart J 2000;21: 162–169.
Zipes DP, Roberts D. Pacemaker-Cardioverter-Defibrillator Investigators. Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator. Circulation 1995;92:59–65.
Link MS, Hill SL, Cliff DL, et al. Comparison of the frequency of complications of implantable cardioverterdefibrillators in children versus adults. Am J Cardiol 1999;83:263–266.
Davidson T, LeRoy S, Horwood L. Perceptions of a support seminar for young ICD patients and families. PACE 1998;21:919A.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stefanelli, C.B., Bradley, D.J., Leroy, S. et al. Implantable Cardioverter Defibrillator Therapy for Life-Threatening Arrhythmias in Young Patients. J Interv Card Electrophysiol 6, 235–244 (2002). https://doi.org/10.1023/A:1019509803992
Issue Date:
DOI: https://doi.org/10.1023/A:1019509803992